Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 20, 2025
Date Accepted: Aug 27, 2025

The final, peer-reviewed published version of this preprint can be found here:

Use of and Medical Decision-Making in Portal Messages Among Patients With Type 2 Diabetes: Mixed Methods Study

Liu T, Waselewski EA, Dougherty A, Lee JD, Hill NE, Marzolf BA, Chang T

Use of and Medical Decision-Making in Portal Messages Among Patients With Type 2 Diabetes: Mixed Methods Study

J Med Internet Res 2025;27:e79413

DOI: 10.2196/79413

PMID: 40997326

PMCID: 12463334

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Utilization and Medical Decision-Making in Portal Messages Among Patients with Type 2 Diabetes

  • Terrence Liu; 
  • Eric A. Waselewski; 
  • Ailish Dougherty; 
  • James D. Lee; 
  • Nina E. Hill; 
  • Brianna A. Marzolf; 
  • Tammy Chang

ABSTRACT

Background:

Patient portal messaging allows individuals to communicate directly with their healthcare providers, offering a flexible way of receiving medical advice between visits. Despite the potential for portal messages to enhance access to care, there is a significant gap in understanding of the types of medical decisions that patients and clinicians make through portal messages.

Objective:

Our objective was to characterize the types of medical decisions that are made through portal messaging among adults with type 2 diabetes.

Methods:

Explanatory-sequential mixed methods study

Results:

Overall, 7,653 individuals (51.9% males, 48.1% females; mean age, 62.9 [SD 14.5] years) were included with an average of 6.7 (SD 8.3) portal message encounters per individual .There were 51,160 message encounters among our study cohort, with an average of 3.2 (SD 2.8) messages per encounter. Of all portal message encounters, 941 (1.8%) were billed, with billed encounters containing more messages per encounter compared to non-billed encounters on average (5.0 [SD 4.8] vs 3.2 [SD 2.7]). Among all billed message encounters, recommendations from the healthcare team involving adjustments or changes to patient medications was the most common content category (“Pharmacologic Recommendation”, 73.0%), followed by patient-initiated questions related to their medications (“Medication Questions”, 64.7%), then medical recommendations from the healthcare team not involving medications (“Non-Pharmacologic Counseling”, 61.4%).

Conclusions:

As national reimbursement policies promote portal messaging to deliver care that would otherwise occur through traditional medical visits, our findings improve our understanding of medical decision-making in portal messages and underscore its role in enhancing patient access to care.


 Citation

Please cite as:

Liu T, Waselewski EA, Dougherty A, Lee JD, Hill NE, Marzolf BA, Chang T

Use of and Medical Decision-Making in Portal Messages Among Patients With Type 2 Diabetes: Mixed Methods Study

J Med Internet Res 2025;27:e79413

DOI: 10.2196/79413

PMID: 40997326

PMCID: 12463334

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.